Previous 10 | Next 10 |
home / stock / mdx:cc / mdx:cc news
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX ) is pleased to announce that it is proposing a non-brokered Private Placement to accredited investors of up to $4 million by issuance of up to 80 Series III Convertible Loan Notes, ea...
MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that it has received final Acceptance from the TSX Venture Exchange in respect of the Closing of the placement of Series II C...
MedX appoints Naman Demaghlatrous to its Board of Directors MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that Naman Demaghlatrous has been appointed t...
MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, announced its financial results for the three-months ended March 31, 2022, which are also available on SEDAR ( www.sedar.com ). “We are encouraged by s...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX) has announced that, in connection with the Private Placement ( the “ Financing ”) originally announced in its press release dated March 1, 2022, and the first Closing of $1 ...
After a successful pilot, MedX Health and Makromed/Arhan Global A.Ş have entered into a long-term commercial distribution agreement with an immediate commitment to purchase 40 SIAscope units MedX Health Corp. (" MedX " or the " Company ") (TSXV: MDX) is pl...
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the year ended December 31, 2021, which are also available on SEDAR ( www.sedar.com ). The Company reported revenue of $563,101 for the year ended December 31, 2021, co...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX) is pleased to announce that in connection with the Private Placement ( the “ Financing ”) originally announced in its press release dated March 1, 2022, and the first Closin...
After a successful pilot program MedX Health and Vitamed Biomedical have entered into a long-term commercial distribution agreement with an immediate commitment to purchase 40 SIAscope units MedX Health Corp. (" MedX " or the " Company ") ( TSXV: MDX ), a glo...
MedX Board of Directors names Naman Demaghlatrous as President and Chief Executive Officer MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that Naman Demaghl...
News, Short Squeeze, Breakout and More Instantly...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announces that it has completed the Initial Closing of the Private Placement originally announced on May 1, 2024, by issuance of 7,142,856 Units (as described below) to raise $500,000. A cash commissi...
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered Private Placement of up to $2 million, which was previously announced on May 1, 2024, will be e...
MedX Health Corp. (MDX:CA) is expected to report for Q1 2024